about
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaTherapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus InfectionManagement of hepatitis delta: Need for novel therapeutic optionsPrevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam.Prevalence and molecular characterization of hepatitis D virus in Saudi Arabia: A single-center study.Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis.Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, ChinaHigh prevalence and significance of hepatitis D virus infection among treatment-naïve HBsAg-positive patients in Northern Vietnam.Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis.Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia.Phylogenetic analysis of HDV isolates from HBsAg positive patients in Karachi, Pakistan.Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysisCorrelation between TH1 response standard cytokines as biomarkers in patients with the delta virus in the western Brazilian AmazonSeroepidemiology of Plasmodium species infections in Zimbabwean population.Multiple infections and cancer: implications in epidemiology.Hepatitis D virus coinfection and superinfectionHepatitis delta: virological and clinical aspects.Clade homogeneity and low rate of delta virus despite hyperendemicity of hepatitis B virus in Ethiopia.Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study.Analysis on the clinical features of 507 HDV-infected patients.Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantification.Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B.Hepatitis D virus in Victoria 2000-2009.Viral hepatitis in solid organ transplantation.Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova.Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.HDV infection rates in northern Vietnam.Anti-HDV seroprevalance among patients with previous HBV infectionCurrent Concept in the Pathophysiology of Hepatitis Delta Infection
P2860
Q26773251-0D2352E4-E1BA-41E4-82DA-0107428A0633Q26795919-0A8A94AF-0AA0-4864-85D2-8FB482FC2EE1Q28082312-B97EEA7A-D96D-47A6-8085-091DB186CB14Q33558023-FC7A9FFF-4442-494D-9804-FFEB69326B6AQ33796525-0FA95E9E-F8C0-4F02-BE92-8EAF7DF8CF7AQ33807794-E943C04B-7230-4F29-9C84-07184A10BFA5Q33872970-11F5AAE7-8DC1-4BAA-85EB-65FCE897E345Q34404998-5FEFEE85-0F11-4404-97AF-9CCB1B104016Q34757956-E6456094-6116-4FC2-9777-8C7E31538F75Q35036020-104DFC7D-1F75-4ECB-B8C4-6DD09562F3C6Q35764198-F583BFFF-C71A-4247-94F0-AA38392806F1Q36203353-77E0CC5A-6207-4B6B-AFAE-DA8BAB2A39D8Q36384122-9A45A3F4-8D42-42DF-ACBE-D73F5B1AC041Q36719999-BDEF7209-6155-4C1C-8762-59F6CC5D63CAQ36793890-06C0955C-4E1A-4B30-A50C-9557D584393AQ36890504-CA6BC4F7-59FC-4E55-BCB5-FBFE9A5758E0Q38126931-B392F316-B71E-4B1A-81B5-DB9ACAA208F3Q38264872-C2224936-B2A6-4AFE-9DEF-682B17207B85Q40042818-7D456B89-D099-4D35-8535-BB62970555DEQ40045086-4E684612-F4F0-4EFE-B23C-8620D1660711Q40724715-CC1BF79F-95F7-4E51-8CBA-EF77F0C36169Q42202348-BC099C60-9159-4C5C-9ED1-67069EAF4156Q42208612-33135F39-4086-4B01-B850-E78CCEE32497Q42234793-857AC715-DB33-4AC9-923E-43C0BD859A11Q42254477-F20B199F-2C11-4903-A14F-17995A428B5BQ42272319-922966FE-DD46-4E85-BD29-62089ECEB362Q45325088-39456F19-6945-4D80-B4D2-A5541CBDC30DQ45366842-A8766890-7AC3-4AF4-BF23-A8D1A0993C80Q55119850-A7D5D920-483E-4037-9B89-15E376A8D43AQ58131335-7868C8FD-E620-43BA-9808-CE6ABBFCA6B7Q58945256-9BC11D1B-E79C-436C-B916-98E73CE50E09
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hepatitis D virus: an update.
@ast
Hepatitis D virus: an update.
@en
Hepatitis D virus: an update.
@nl
type
label
Hepatitis D virus: an update.
@ast
Hepatitis D virus: an update.
@en
Hepatitis D virus: an update.
@nl
prefLabel
Hepatitis D virus: an update.
@ast
Hepatitis D virus: an update.
@en
Hepatitis D virus: an update.
@nl
P2860
P1433
P1476
Hepatitis D virus: an update.
@en
P2093
Francesco Negro
Stéphanie Pascarella
P2860
P356
10.1111/J.1478-3231.2010.02320.X
P577
2010-09-29T00:00:00Z